Pyx Health is a technology-enabled health services company founded in 2017 that addresses loneliness and social isolation as a chronic health condition. The company offers the first evidence-based, data-driven loneliness solution for health plan members, and has expanded into addressing non-medical drivers of health. Pyx Health partners with major health plans, including Wellpoint and Delaware First Health.

ReSuture is a surgical training and medical device development company that builds high-fidelity, procedure-specific vascular simulations with capacitive sensing technology. Its patient- and disease-specific procedural trainers enable quantitative surgical performance evaluation, aiming to establish a new gold standard for surgical education. In 2023, ReSuture was awarded an NSF Phase II SBIR grant to support its surgical performance and medical device development platform.

Siamab Therapeutics is a biopharmaceutical company developing novel cancer therapeutics that target cancer-specific carbohydrate antigens (glycans) expressed on cancer cells. The company focuses on antibody-based therapies directed at abnormal carbohydrate structures unique to tumor cells. In 2019, Siamab completed a $202 million exit, notable for being angel-funded throughout its development.

Ansella Therapeutics is a specialty pharmaceutical company that leverages biomimetic sciences to develop novel therapeutics that improve healthcare outcomes, with a focus on vaginal health conditions. The company applies detailed understanding of well-known biological systems to develop treatments that address often overlooked areas of women's health.

Aural Analytics is a clinical-grade speech analytics company that harnesses the clinical utility of speech to provide non-invasive, actionable neurological insights for clinical decision makers focused on brain health monitoring. The company was acquired by Linus Health in March 2024 to support early detection of Alzheimer's and other dementias.

Avery Therapeutics is a company dedicated to developing tissue-engineered therapeutics to treat diseases and injuries to human muscle. A startup spun out of the University of Arizona, the company is advancing first-in-class immunomodulatory therapeutics to redirect the immune system to address diseases of aging and inflammation.

Basata is an AI-powered platform that streamlines document management and call center operations for healthcare practices, helping reduce administrative backlog so clinical teams can focus on patient care.

Beacon Biomedical Inc. is a CLIA-accredited proteomic diagnostics laboratory focused on developing and commercializing laboratory-developed tests, including a diagnostic device designed to detect colorectal cancer in its early stages. The company raised $1.47M and was later acquired by CashLabs LLC in 2022.

BeCareLink provides validated, quantitative measurements of neurologic function and cognition, supplemented by AI analysis to improve patient care. The company delivers quantifiable neurological assessments via remote monitoring to help manage chronic neurological conditions and empower patients.

BioSpeedia is a biotechnology company founded by two scientific researchers from Institut Pasteur, focused on the production of diagnostic test kits for infectious diseases. The company develops rapid, validated diagnostic solutions leveraging deep scientific expertise from one of the world's leading biomedical research institutions.

Blackrock Neurotech is a neurotechnology company focused on developing implantable brain-computer interfaces (BCIs) to help people with neurological conditions regain lost function. The company brings together engineers, neuroscientists, and clinicians and has partnered with Cognixion to supply its technology for wearable neural interface platforms.

Calimmune, Inc. was a clinical-stage gene therapy company that developed and commercialized lentiviral gene therapies for sickle cell disease and beta-thalassemia, including its lead asset CAL-H using the Select+™ stem cell gene therapy platform. The company was acquired by CSL Behring in 2017.

Cancer Prevention Pharmaceuticals, Inc. is a clinical-stage company developing therapeutics designed to reduce the risk and recurrence of cancer and rare diseases. The company was acquired by Panbela Therapeutics (Nasdaq: PBLA) in June 2022.

DeepLook Medical is a Scottsdale, AZ-based medical imaging company that applies AI software to advance radiology through enhanced imaging resolution, with a focus on breast imaging. Its technology enables providers to detect and diagnose soft lesions with unprecedented precision. The company expanded globally after relocating to Scottsdale and securing new funding in 2026.

Delta Development Team is a pioneering company in transportable blood storage solutions, transforming cold chain logistics with advanced thermal systems. The company is a market leader in portable blood management, combining ruggedized hardware with cloud-connected software to support medical and military logistics.

Duo Oncology is a cancer medicine company developing next-generation chemotherapy for solid tumors using ultrasmall, tumor-penetrating nanomedicines that deliver drug combinations to deep tumors. Its lead program, DUO-207, is designed to improve on existing chemotherapy approaches. The company is backed by BeOne and brings together clinical oncologists and pharmaceutical scientists.

EndoVantage developed computational tools for clinicians to personalize the planning of endovascular treatments, with a focus on cerebral aneurysm management through its Find, Track and Treat platform. The company was acquired by RapidAI in June 2020, integrating its aneurysm management technology into RapidAI's broader AI-powered neurological care platform.

Enquyst Technologies is a biotechnology company disrupting the way biological drugs are manufactured through next-generation bioprocess and analytical technologies. The early-stage company is focused on developing innovative, pathbreaking tools to improve the efficiency and quality of biopharmaceutical production.

EVQLV is a biotechnology company that leverages advances in computation to accelerate the design and development of therapeutic antibodies. Its proprietary computational platform generates diverse, fully-human antibodies, aiming to accelerate the speed that healing reaches patients. The company's platform is designed to make AI accessible to antibody scientists.